Peter Marks, M.D., Ph.D., director of CBER at FDA gives a disturbingly casual response when asked about creating targeted, new avian flu vaccines + the potential to deploy Emergency Use Authorization ‘if we had to.’

Watch the ENTIRE hearing — ‘Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices’ — on #CHDTV ?


https://childrenshealthdefense.org/defender/bp-fda-approves-moderna-rsv-vaccine-seniors-second-ever-product/?utm_source=sovren&utm_medium=social&utm_campaign=defender&utm_id=20240603